Search Results 351-360 of 17395 for alopecia
4.03 Grade > 1); however, alopecia, sensory neuropathy Grade ≤ 2, or other Grade ≤ 2 not constituting a safety risk based on Investigator's judgment are ...
... Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Vulvar skin disorder, Breast skin change, Rosacea, Pigmentation disorder ...
... . VID-20522543. Home; Cerebral palsy. 5X Challenge is here! 5X My Gift! Your gift today can have 5X the impact on AI research and technology.
... alopecia - Patients who are receiving any other investigational agents - Patients with uncontrolled intercurrent illness - Patients who cannot discontinue ...
(which must be ≤ grade 2), alopecia and/or endocrinopathies related to prior immunotherapy which are controlled with hormone replacement. - Patients must ...
... alopecia, and hypothyroidism that is controlled with hormone replacement therapy). Active, known, or suspected autoimmune disease. Note: Patients with type ...
Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid. J Drugs Dermatol. 2022 Aug 1; 21 (8):894-895. View PubMed; Smith SDB, Okoye GA ...
Geographic tongue may look alarming, but it does not cause health issues. Sometimes it can cause tongue pain and make you more sensitive to certain foods.
... . VID-20115891. Home; Brightcove-Stroke Patient Story. 5X Challenge is here! 5X My Gift! Your gift today can have 5X the impact on AI research and ...
2024 marks a pivotal year for advancing artificial intelligence (AI) solutions in healthcare, requiring multidisciplinary teamwork and scientific rigor to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.